Adenocarcinoma dell'endometrio insorto durante terapia con tamoxifene: Descrizione di un caso clinico

Translated title of the contribution: Endometrial carcinoma during tamoxifen therapy. A case report

M. Valenzano Menada, A. Corticelli, A. Giannesi, L. Nicoletti, M. Podestà, R. Rissone, E. Fulcheri

Research output: Contribution to journalArticlepeer-review

Abstract

Tamoxifen is a non-steroid estrogenic antagonist, used in post-surgical therapy of breast cancer. It interferes with endocrinous promotion of breast cancer. Tamoxifen could determine endometrial, even carcinomatous, alterations. The case of a postmenopausal patient surgically treated for breast cancer and successively treated with tamoxifen (20 mg/die), is reported. She underwent ultrasonographic and hysterosonographic endometrial evaluation and finally a hysterectomy with bilateral annessiectomy. This case seems to confirm tamoxifen possible carcinogenical effects on the endometrium.

Translated title of the contributionEndometrial carcinoma during tamoxifen therapy. A case report
Original languageItalian
Pages (from-to)521-526
Number of pages6
JournalMinerva Ginecologica
Volume52
Issue number12
Publication statusPublished - Dec 2000

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Fingerprint Dive into the research topics of 'Endometrial carcinoma during tamoxifen therapy. A case report: Descrizione di un caso clinico'. Together they form a unique fingerprint.

Cite this